The United Kingdom is witnessing a noticeable surge in interest surrounding mind-altering substances. Beyond the common use of psilocybin and LSD, scientists and enthusiasts are increasingly delving into less-charted areas, particularly copyright and the budding cannabinoid, CBG compound. This burgeoning scene encompasses therapeutic research into